Adverse event reporting practices in drug-resistant tuberculosis facilities across South Africa

dc.date.accessioned	2024-02-29T13:02:40Z
dc.date.available	2024-02-29T13:02:40Z
dc.date.issued	2024-02-21	en
dc.identifier.issn	2312-0053	en
dc.identifier.uri	http://hdl.handle.net/20.500.11910/23008
dc.description.abstract	The reporting of adverse drug reactions associated with drug-resistant tuberculosis (DR-TB) medication is important for pharmacovigilance, especially in high burden countries such as South Africa. With DR-TB treatment being so dynamic, it is important to understand adverse event reporting practices at specialised facilities.	en
dc.format.medium	Print	en
dc.subject	TUBERCULOSIS	en
dc.subject	CLINICAL TREATMENT	en
dc.subject	DRUG RESISTANCE	en
dc.title	Adverse event reporting practices in drug-resistant tuberculosis facilities across South Africa	en
dc.type	Journal Article	en
dc.description.version	Y	en
dc.ProjectNumber	N/A	en
dc.Volume	38(1)	en
dc.BudgetYear	2023/24	en
dc.ResearchGroup	Public Health, Societies and Belonging	en
dc.SourceTitle	Southern African Journal of Infectious Diseases	en
dc.ArchiveNumber	9814288	en
dc.PageNumber	Online	en
dc.outputnumber	14945	en
dc.bibliographictitle	Gaida, R., Davids, A.S. & Sewpaul, R. (2023) Adverse event reporting practices in drug-resistant tuberculosis facilities across South Africa. Southern African Journal of Infectious Diseases. 38(1):Online. http://hdl.handle.net/20.500.11910/23008	en
dc.publicationyear	2023	en
dc.contributor.author1	Gaida, R.	en
dc.contributor.author2	Davids, A.S.	en
dc.contributor.author3	Sewpaul, R.	en

Files in this item

Files	Size	Format	View
There are no files associated with this item.